Publications by authors named "Yuasa Akira"

Claim this Profile
Q
Quantifying Disease Severity in Health Technology Assessment in Japan: A Retrospective Analysis Using Quality-Adjusted Life-Year Shortfalls.
Miwa Enami, Akira Yuasa, Shunya Ikeda

J Health Econ Outcomes Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Differences Between Manufacturers and Public Analyses in Health Technology Assessment in Japan.
Yoko Hirano, Akira Yuasa, Karin Matsumoto, Hiroshi Nakamura

J Health Econ Outcomes Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Hip Osteoarthritis with Severe Acetabular Bone Defects by Total Hip Arthroplasty Using the Restoration GAP II Reinforcement Ring: A Case Report.
Akira Yuasa, Hiroki Kobayashi, Keisuke Horiuchi

J Orthop Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.
Norimitsu Saito, Kazumasa Kamei, Genevieve Gautier, Samantha K Kurosky, Kent A Hanson, Akira Yuasa

J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patient's financial burden of COVID-19 treatment on antiviral prescription rates and clinical and economic outcomes.
Mitsuhiro Nagano, Sachiko Hyokai, Kanae Togo, Tendai Mugwagwa, Akira Yuasa

Expert Rev Pharmacoecon Outcomes Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared with Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan.
Akira Yuasa, Hiroyuki Matsuda, Yosuke Fujii, Tendai Mugwagwa, Yuki Kado

J Health Econ Outcomes Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in Japan.
Takao Takeshima, Akira Yuasa, Yukie Michelle Lloyd, Louis Patrick Watanabe, Kazumasa Kamei

Neurol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
Akio Tanaka, Akira Yuasa, Kazumasa Kamei, Mitsuhiro Nagano, Toshiaki Murofushi

J Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis.
Tetsuya Matsumoto, Akira Yuasa, Hiroyuki Matsuda, Dilinuer Ainiwaer, Naohiro Yonemoto

Infect Dis Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact survey 2020.
Ana Paula A Bueno, Otavio Clark, Matthew Turnure, Eloisa S Moreira, Akira Yuasa

Future Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real-world data.
Manabu Ohyama, Kazumasa Kamei, Akira Yuasa, Peter Anderson, Gary Milligan

J Dermatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan.
Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu

Infect Dis Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan.
Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu

Infect Dis Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.
Taku Kobayashi, Masato Hoshi, Akira Yuasa, Shoko Arai, Mitsunobu Ikeda

Pharmacoeconomics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study.
Tetsuya Matsumoto, Akira Yuasa, Ryan Miller, Clive Pritchard, Takahisa Ohashi

Pharmacoecon Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders.
Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Toshiaki Murofushi, Michael LoPresti

Adv Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria.
Atsuyuki Igarashi, Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Michael LoPresti

Dermatol Ther (Heidelb)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons.
Taisuke Ito, Kazumasa Kamei, Akira Yuasa, Fumihiro Matsumoto, Yayoi Hoshi

J Dermatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan.
Tomoyuki Takura, Akira Yuasa, Naohiro Yonemoto, Sven Demiya, Hiroyuki Matsuda

Pharmacoecon Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for growth hormone treatment in Japanese children.
Toshiaki Tanaka, Takahiro Sato, Akira Yuasa, Takeshi Akiyama, Adeeb Tawseef

Pediatr Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.
Tetsuya Matsumoto, Oliver Darlington, Ryan Miller, Jason Gordon, Phil McEwan, Akira Yuasa

J Health Econ Outcomes Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review.
Akira Yuasa, Naohiro Yonemoto, Michael LoPresti, Shunya Ikeda

Expert Rev Pharmacoecon Outcomes Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries.
Akira Yuasa, Naohiro Yonemoto, Sven Demiya, Chihiro Foellscher, Shunya Ikeda

Pharmacoecon Open· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.
Akira Yuasa, Naohiro Yonemoto, Michael LoPresti, Shunya Ikeda

Pharmacoeconomics· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment procedures and associated medical costs of methicillin-resistant infection in Japan: A retrospective analysis using a database of Japanese employment-based health insurance.
Akira Yuasa, Tatsunori Murata, Keiji Imai, Yuji Yamamoto, Yoko Fujimoto

SAGE Open Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis